Sun Pharmaceutical Industries Profit & Loss Annual
BSE: - | NSE: - | ISIN: - | Sector: -| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 46,216.15 | 40,674.51 | 38,479.92 | 34,793.33 |
| Other Net | 1,971.72 | 346.07 | -145.70 | 27.31 |
| Diluted Weighted Average Shares | 240.16 | 239.93 | 239.93 | 239.93 |
| Depreciation/ Amortization | 2,937.85 | 2,575.39 | 2,556.79 | 2,529.43 |
| Total Extraordinary Items | 385.40 | - | - | - |
| Operating Income | 12,245.89 | 11,903.93 | 10,016.93 | 9,092.35 |
| Net Income | 11,479.42 | 10,929.04 | 9,576.38 | 8,473.58 |
| Income Availableto Com Excl Extra Ord | 11,094.02 | 10,929.04 | 9,576.38 | 8,473.58 |
| Other Operating Expenses Total | 19,008.28 | 1,154.98 | 1,189.04 | 738.24 |
| Net Income Before Taxes | 15,118.88 | 13,752.13 | 11,087.89 | 9,408.43 |
| Minority Interest | -29.23 | -35.71 | -33.65 | -39.36 |
| Net Income After Taxes | 11,179.12 | 10,980.10 | 9,648.44 | 8,560.84 |
| Income Availableto Com Incl Extra Ord | 11,479.42 | 10,929.04 | 9,576.38 | 8,473.58 |
| Costof Revenue Total | 11,543.68 | 12,197.51 | 12,069.66 | 11,942.42 |
| Gross Profit | 46,918.36 | 40,380.93 | 36,427.19 | 31,943.26 |
| Interest Inc( Exp) Net- Non- Op Total | 901.27 | 1,496.78 | 1,226.63 | 281.23 |
| Unusual Expense( Income) | 1,307.48 | 718.69 | 492.72 | 188.37 |
| Diluted Net Income | 11,479.42 | 10,929.04 | 9,576.38 | 8,473.58 |
| DPS- Common Stock Primary Issue | 16.00 | 16.00 | 13.50 | 11.50 |
| Provisionfor Income Taxes | 3,939.76 | 2,772.03 | 1,439.45 | 847.59 |
| Equity In Affiliates | -55.87 | -15.35 | -38.41 | -47.90 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 11,094.02 | 10,929.04 | 9,576.38 | 8,473.58 |
| Total Revenue | 58,462.04 | 52,578.44 | 48,496.85 | 43,885.68 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 58,462.04 | 52,578.44 | 48,496.85 | 43,885.68 |
| Selling/ General/ Admin Expenses Total | 11,418.86 | 24,027.94 | 22,171.71 | 19,394.87 |
| Diluted Normalized EPS | 50.22 | 47.92 | 41.74 | 36.01 |
| Diluted EPS Excluding Extra Ord Items | 46.20 | 45.55 | 39.91 | 35.32 |
| Gain( Loss)on Saleof Assets | - | 5.35 | -9.97 | 7.54 |
Sun Pharmaceutical Industries Quick Links
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Cashflow Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.